Turinys
- EN English
Strategic inquiry into pre‐submission activities organised by the European Medicines Agency (OI/7/2017/KR).
Pradėta byla
Byla OI/7/2017/KR - Atidaryta Pirmadienis | 17 liepos 2017 - Sprendimas Trečiadienis | 17 liepos 2019 - Atitinkama institucija Europos vaistų agentūra ( Tolesnis tyrimas nėra pateisinamas ) - Šalis Prancūzija
The European Ombudsman, Emily O'Reilly, has opened an inquiry into the pre-submission activities that the European Medicines Agency (EMA) offers to individual medicine developers before the Agency receives applications for marketing authorisations from them.
Susiję dokumentai
Atvejis OI/7/2017/KR
- Antradienis | 26 lapkričio 2019Bylos aprašymas
Ombudsman inquiry strengthens transparency and objectivity of EMA's assessment of new medicines
- Antradienis | 26 lapkričio 2019Sprendimas
- Trečiadienis | 26 birželio 2019Patikrinimo ataskaita
- Trečiadienis | 26 birželio 2019Patikrinimo ataskaita
- Pirmadienis | 08 spalio 2018Viešoji konsultacija
- Antradienis | 19 gruodžio 2017Patikrinimo ataskaita
- Ketvirtadienis | 21 lapkričio 2019Korespondencija
- Penktadienis | 03 gegužės 2019Korespondencija
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from the Main Association of Austrian Social Security Institutions
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from the International Society of Drug Bulletins
- Antradienis | 05 vasario 2019Korespondencija
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from the Federation of Veterinarians of Europe
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from the Norwegian Medicines Agency
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from the Medicines Evaluation Board of the Netherlands
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from the European Patients’ Forum
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from FIMEA, the Finnish Medicines Agency
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from the European Public Health Alliance (EPHA)
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from the French Agency for Veterinary Medicinal Products
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from the Danish Medicines Agency
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from the European Organisation for Rare Diseases (Eurordis)
- Antradienis | 05 vasario 2019Korespondencija
Submission to the consultation from Health Action International
- Antradienis | 05 vasario 2019Korespondencija
- Pirmadienis | 04 vasario 2019Korespondencija
Submission to the consultation from the German Pharmaceutical Industry Association
- Pirmadienis | 04 vasario 2019Korespondencija
Submission to the consultation from the National Institute for Health and Care Excellence, UK
- Pirmadienis | 04 vasario 2019Korespondencija
Submission to the consultation from the Austrian Medicines and Medical Devices Agency
- Pirmadienis | 04 vasario 2019Korespondencija
Submission to the consultation from BEUC, European Consumer Organization
- Pirmadienis | 04 vasario 2019Korespondencija
Submission to the consultation from the Swedish Medical Products Agency
- Pirmadienis | 04 vasario 2019Korespondencija
Submission to the consultation from the Institute for Quality and Efficiency in Health Care (IQWiG)
- Pirmadienis | 04 vasario 2019Korespondencija
- Pirmadienis | 04 vasario 2019Korespondencija
- Pirmadienis | 04 vasario 2019Korespondencija
Submission to the consultation from the European Social Insurance Platform
- Pirmadienis | 04 vasario 2019Korespondencija
Submission to the consultation from the Standing Committee of European Doctors
- Pirmadienis | 04 vasario 2019Korespondencija
- Penktadienis | 01 vasario 2019Korespondencija
Submission to the consultation from the Heads of Medicines Agencies (HMA)
- Ketvirtadienis | 31 sausio 2019Korespondencija
- Ketvirtadienis | 31 sausio 2019Korespondencija
Submission to the consultation from the European Association for Bioindustries, EuropaBio
- Trečiadienis | 30 sausio 2019Korespondencija
- Antradienis | 22 sausio 2019Korespondencija
Submission to the consultation from Ludwig Boltzmann Institute for Health Technology Assessment
- Antradienis | 22 sausio 2019Korespondencija
Submission to the consultation from the German Association of Statutory Health Insurance Funds
- Antradienis | 22 sausio 2019Korespondencija
- Antradienis | 22 sausio 2019Korespondencija
Submission to the consultation from Fondazione Telethon / Istituto San Raffaele Telethon
- Trečiadienis | 16 sausio 2019Korespondencija
Submission to the consultation from the European Forum for Primary Care
- Sekmadienis | 13 sausio 2019Korespondencija
- Ketvirtadienis | 10 sausio 2019Korespondencija
- Ketvirtadienis | 20 gruodžio 2018Korespondencija
- Antradienis | 18 gruodžio 2018Korespondencija
Submission to the consultation from the Association of European Cancer Leagues (ECL)
- Ketvirtadienis | 31 rugpjūčio 2017Korespondencija
- Pirmadienis | 17 liepos 2017Korespondencija